Actively Recruiting
Duration of Peripheral Nerve Blocks in Opioid Tolerant Individuals - A Volunteer Blinded Matched Case-control Study
Led by Charlotte Runge · Updated on 2024-07-05
40
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Do peripheral nerve blocks work shorter if you are on opioids? Background: Peripheral nerve blocks effectively alleviate postoperative pain. Animal studies and human research indicate that opioid tolerance results in reduced effectiveness of local analgesics. This applies to both central nerve blockade and infiltration anaesthesia. The impact on peripheral nerve block in humans has not been evaluated. The aim of the study is to assess the onset time and duration of a radial nerve block in opioid tolerant individuals compared to opioid naive individuals. We hypothesise that peripheral nerve blocks cause shorter sensory and motor block in opioid-tolerant compared to opioid-naive counterparts. Methods: Twenty opioid-tolerant individuals will be matched by sex and age with opioid-naïve counterparts. Participants will undergo an ultrasound-guided radial nerve block. The onset time and duration of motor and sensory blockade will be tested and measured. The primary outcome is difference in duration of sensory nerve blockade between the two groups. The secondary outcomes include the onset time of sensory blockade, onset time of motor blockade, and difference in duration of motor nerve blockade. Perspectives: The data from this study will provide evidence for the duration of peripheral nerve block in opioid tolerant individuals and support if a specific postoperative protocol for opioid tolerant individuals is needed or it should be of special attention.
CONDITIONS
Official Title
Duration of Peripheral Nerve Blocks in Opioid Tolerant Individuals - A Volunteer Blinded Matched Case-control Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- ASA physical status classification 1 to 3
- For opioid group: chronic pain lasting more than three months
- For opioid group: daily use of more than 60 mg morphine equivalent opioids for more than 7 days
- For opioid naive group: no opioid use within 30 days prior to participation
- Legally competent and able to give informed consent
You will not qualify if you...
- Age over 84 years
- Unable to cooperate with the study
- Cannot understand or speak Danish
- Allergy to lidocaine or its preservatives
- Alcohol or drug abuse other than opioids
- Peripheral neuropathy in the upper limb non-dominant arm
- Previous major surgery or pathology of the upper limb
- Active infection at the injection site
- Pregnancy
- Partial or complete 2nd or 3rd degree atrioventricular heart block without a pacemaker
- Severe liver disease
- Severe kidney disease with eGFR below 30 mL/min
- Daily treatment with drugs related to local analgesics or class IB antiarrhythmics
- Daily treatment with class III antiarrhythmics such as amiodarone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Silkeborg Regional Hospital
Silkeborg, Denmark, 8600
Actively Recruiting
Research Team
M
Mikkel SH Jensen, MD
CONTACT
C
Charlotte Runge, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here